Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v6-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2024-04-10 | 2024-01-09 |
| Drug Identification Number | 02260565 | 02260565 |
| Brand name | XOLAIR | XOLAIR |
| Common or Proper name | XOLAIR 150MG/5ML VIALS 1 X 1 | XOLAIR 150MG/5ML VIALS 1 X 1 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC | NOVARTIS PHARMACEUTICALS CANADA INC |
| Ingredients | OMALIZUMAB | OMALIZUMAB |
| Strength(s) | 150MG | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 x 5mL | 1 x 5mL |
| ATC code | R03DX | R03DX |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2024-01-31 | 2024-01-31 |
| Actual start date | 2024-01-25 | |
| Estimated end date | 2024-03-31 | 2024-03-31 |
| Actual end date | 2024-04-09 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | No projected impact to pre-filled syringe | No projected impact to pre-filled syringe |
| Health Canada comments |